المؤلفون: Namiki T; Department of Japanese-Oriental (Kampo) Medicine, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan. tnamiki@faculty.chiba-u.jp., Takayama S; Department of Kampo Medicine, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.; Department of Education and Support for Regional Medicine, Tohoku University Hospital, 1- 1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.; Department of Kampo and Integrative Medicine, Tohoku University Graduate School of Medicine, 1-2, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan., Arita R; Department of Kampo Medicine, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.; Department of Education and Support for Regional Medicine, Tohoku University Hospital, 1- 1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan., Ishii T; Department of Kampo Medicine, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.; Department of Education and Support for Regional Medicine, Tohoku University Hospital, 1- 1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.; Department of Kampo and Integrative Medicine, Tohoku University Graduate School of Medicine, 1-2, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan., Kainuma M; Community Medicine Education Unit, Graduate School of Medical Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan., Makino T; Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-Dori, Mizuho-ku, Nagoya, 467-8603, Japan., Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Yoshino T; Center for Kampo Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Nogami T; Department of Kampo Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan., Arai M; Department of Kampo Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan., Sato J; Department of General Medicine/Family & Community Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan., Tanaka K; Department of Traditional Medicine, Faculty of Medicine, Toho University, 5-21-16, Omorinishi, Ota-ku, Tokyo, 143-8540, Japan., Nakae H; Department of Emergency and Critical Care Medicine, Akita University Graduate School of Medicine, 44-2 Hasunuma Hiroomote, Akita, 010-8543, Japan., Igari H; Department of Infectious Diseases, Chiba University Hospital, School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8677, Japan., Ozawa Y; Biostatistics Section, Clinical Research Center, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan., Shiko Y; Biostatistics Section, Clinical Research Center, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan., Kawasaki Y; Faculty of Nursing, Japanese Red Cross College of Nursing, Tokyo, 150-0012, Japan., Nezu M; Department of Japanese-Oriental (Kampo) Medicine, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan., Ito T; Akashi Clinic Kanda, 3-8, Kandaogawamachi, Chiyodaku, Tokyo, 101-0052, Japan.

المصدر: Trials [Trials] 2021 Jan 06; Vol. 22 (1), pp. 23. Date of Electronic Publication: 2021 Jan 06.

نوع المنشور: Clinical Trial Protocol; Letter

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19/*prevention & control , Drugs, Chinese Herbal/*administration & dosage , Medicine, Kampo/*methods , Pandemics/*prevention & control , SARS-CoV-2/*isolation & purification, Administration, Oral ; Adult ; Aged ; COVID-19/diagnosis ; COVID-19/epidemiology ; COVID-19/virology ; COVID-19 Nucleic Acid Testing ; Drug Administration Schedule ; Drugs, Chinese Herbal/adverse effects ; Female ; Humans ; Japan/epidemiology ; Male ; Medicine, Kampo/adverse effects ; Middle Aged ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Risk Factors ; Severity of Illness Index ; Treatment Outcome ; Young Adult

المؤلفون: Takayama S; Department of Kampo Medicine, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. takayama@med.tohoku.ac.jp.; Department of Education and Support for Regional Medicine, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. takayama@med.tohoku.ac.jp.; Department of Kampo and Integrative Medicine, Tohoku University Graduate School of Medicine, 1-2, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan. takayama@med.tohoku.ac.jp., Namiki T; Department of Japanese-Oriental (Kampo) Medicine, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan., Ito T; Akashi Clinic Kanda, 3-8, Kandaogawa-machi, Chiyoda-ku, Tokyo, 101-0052, Japan., Arita R; Department of Kampo Medicine, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.; Department of Education and Support for Regional Medicine, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan., Nakae H; Department of Emergency and Critical Care Medicine, Akita University Graduate School of Medicine, 1-1-1, Hondo, Akita, 010-8543, Japan., Kobayashi S; Department of Respiratory Medicine, Japanese Red Cross Ishinomaki Hospital, Nishimichishita-71, Hebita, Ishinomaki, 986-8522, Japan., Yoshino T; Center for Kampo Medicine, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Ishigami T; Department of Cardiology, Yokohama City University Hospital, 3-9, Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Tanaka K; Department of Traditional Medicine, Faculty of Medicine, Toho University, 6-11-1, Omori-nishi, Ota-ku, Tokyo, 143-8541, Japan., Kainuma M; Community Medicine Education Unit, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan., Nochioka K; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan., Takagi A; Clinical Research Data Center, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan., Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan., Yamaguchi T; Division of Biostatistics, Tohoku University Graduate School of Medicine, 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan., Ishii T; Department of Kampo Medicine, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.; Department of Education and Support for Regional Medicine, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.; Department of Kampo and Integrative Medicine, Tohoku University Graduate School of Medicine, 1-2, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.

المصدر: Trials [Trials] 2020 Oct 02; Vol. 21 (1), pp. 827. Date of Electronic Publication: 2020 Oct 02.

نوع المنشور: Clinical Trial Protocol; Letter

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

مواضيع طبية MeSH: Medicine, Kampo*, Antiviral Agents/*therapeutic use , Betacoronavirus/*drug effects , Coronavirus Infections/*drug therapy , Drugs, Chinese Herbal/*therapeutic use , Pneumonia, Viral/*drug therapy, Antiviral Agents/adverse effects ; Betacoronavirus/pathogenicity ; COVID-19 ; Coronavirus Infections/diagnosis ; Coronavirus Infections/virology ; Drug Therapy, Combination ; Drugs, Chinese Herbal/adverse effects ; Female ; Host-Pathogen Interactions ; Humans ; Japan ; Male ; Multicenter Studies as Topic ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/virology ; Randomized Controlled Trials as Topic ; SARS-CoV-2 ; Severity of Illness Index ; Time Factors ; Treatment Outcome ; COVID-19 Drug Treatment